生命科学资讯

Chengdu Chipscreen Pharmaceutical describes new Mat2A inhibitors

New SIK inhibitors disclosed in Insilico Medicine patent

Samsung Life Public Welfare Foundation discovers new TLR signaling inhibitors

Otsuka’s IgAN therapy gets a thumbs-up from the FDA

Along with NIH cuts come risks to patient safety and scientific data

Illumina price attacks important resistance - Forecast today - 26-11-2025 - Economies.com

Sanofi headquarters raided in broader French tax fraud investigation

Will Waters Corporation (WAZ) stock rise with strong economy - Weekly Trade Summary & High Accuracy Buy Signal Tips - BỘ NỘI VỤ

How 10x Genomics Inc. stock responds to policy changes - 2025 Volatility Report & Risk Managed Trade Strategies - BỘ NỘI VỤ

Invitation to Roche’s Virtual Oncology/SABCS Investor Event - Roche

Kallyope scraps one of two mid-stage migraine drugs

Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook - Investing.com Australia

Thermo Fisher Scientific Stock: Is TMO Outperforming the Health Care Sector? - Barchart.com

Thermo Fisher Scientific Stock: Is TMO Outperforming the Health Care Sector? - Yahoo Finance

Orlando Roche: First Horizon Bank’s market president will extend his reach - Miami Today

Orlando Roche: First Horizon Bank’s market president will extend his reach - Miami Today

Holding the Line in Pokrovsk - The Dispatch

Agilent Technologies Stock Surges 9.3%, With A 5-Day Winning Spree - Trefis

Ammonia leak at Yakima's Roche Fruit prompts evacuations - Nonstop Local News

Otsuka’s anti-APRIL antibody gets FDA approval for kidney disease IgAN